US 7,405,061 B2Granted

Antigen PIPA and antibodies that bind thereto

AssigneeRaven Biotechnologies, Inc.

InventorsJennie P. Mather, Ronghao Li, Tony W. Liang

Life of this patent

Estimating the term…

Abstract

Provided herein is disclosure about the identification and characterization of disease and cancer associated antigen PIPA. The invention also provides a family of monoclonal antibodies that bind to antigen PIPA, and methods of diagnosing and treating various human cancers and diseases that express PIPA.

Claims42

Dependent claims

An isolated antibody PIP produced by a host cell with a deposit number of ATCC No. PTA-4220.

Dependencies are inferred from the claim text.

Facts

Application: 10/713,248Filed 13 Nov 2003 · us provisional application
Priority: 13 Nov 2002
Published: US 2004/0171814 A12 Sep 2004
Granted: 29 Jul 2008
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

C07K 16/30
Against receptors, cell surface antigens or cell surface determinants: from tumour cells
A61P 35/00
Antineoplastic agents
C07K 2317/73
Characterized by effect upon binding to a cell or to an antigen: inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
C07K 2317/77
Characterized by effect upon binding to a cell or to an antigen: internalization into the cell

Family

Application60/426,192Us provisional application · filed 13 Nov 2002
US 2004/0171814 A1Pre-grant publication · published 2 Sep 2004
US 7,405,061 B2This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results